Takata T, Okumiya T, Hayashibe H, Shimmoto M, Kase R, Itoh K, Utsumi K, Kamei S, Sakuraba H
Department of Clinical Genetics, Tokyo Metropolitan Institute of Medical Science, Japan.
Brain Dev. 1997 Mar;19(2):111-6. doi: 10.1016/s0387-7604(96)00486-x.
We have applied non-radioactive polymerase chain reaction (PCR)-single-stranded conformation polymorphism (SSCP) to the detection of gene mutations causing Fabry disease. Nineteen of 22 known mutations were detected as electrophoretic mobility shifts on PCR-SSCP analysis. Then, DNA from newly diagnosed Japanese patients with the classical form of Fabry disease was subjected to PCR-SSCP analysis, and 4 novel mutations (1 small deletion, 1 nonsense mutation and 2 missense mutations) and 1 neutral polymorphism were identified. Furthermore, identification of an asymptomatic heterozygote and a hemizygote with moderate clinical manifestations was successfully achieved by application of this method to a family with the variant form of Fabry disease. PCR-SSCP is useful for the gene diagnosis of etiologically heterogeneous Fabry disease.
我们已将非放射性聚合酶链反应(PCR)-单链构象多态性(SSCP)应用于法布里病致病基因突变的检测。在PCR-SSCP分析中,22个已知突变中的19个被检测为电泳迁移率改变。然后,对新诊断的典型法布里病日本患者的DNA进行PCR-SSCP分析,鉴定出4个新突变(1个小缺失、1个无义突变和2个错义突变)以及1个中性多态性。此外,通过将该方法应用于患有变异型法布里病的一个家系,成功鉴定出一名无症状杂合子和一名具有中度临床表现的半合子。PCR-SSCP对于病因异质性的法布里病的基因诊断很有用。